RecruitingNCT06531109

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pfizer
Principal Investigator
Pfizer CT.gov Call Center
Pfizer
Intervention
Ritlecitinib(drug)
Enrollment
850 target
Eligibility
12 years · All sexes
Timeline
20242028

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06531109 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials